Medline Inc-cl A (MDLN) SEC 13F Holdings (Q2 2026) — Net Institutional Activity: $5.9B

MDLN ranks #1508 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

MDLN is a disclosed holding of David Rubenstein (Carlyle Group), one of the tracked superinvestors on AlphaSMO — it makes up 73.8% of that fund's own 13F portfolio.

MDLN is a top-conviction position for H&F Corporate Investors X, Ltd. — at 100.0% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in MDLN belongs to Carlyle Group Inc., but the position matters far more to H&F Corporate Investors X, Ltd., who has 100.0% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Invesco Ltd. has added to its MDLN position for two straight quarters, increasing it by $1.4B to reach $1.5B today.

David Rubenstein has trimmed its MDLN position for two straight quarters, cutting it by $1.7B while still holding $7.4B.

MDLN is up 0.2% today, and institutions have been net buyers of $5.9B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

MDLN closed its latest fiscal year with net income of $1.2B, and currently trades at a P/E of 24.5.

• Profitable — net income of $1.2B in the latest fiscal year
• Revenue grew 11.5% year over year
• Net income declined year over year, from $1.2B to $1.2B
• Generated $1.7B in positive operating cash flow
• Current ratio of 4.29x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.79x equity — within a conventional range